Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nucleic Acid Testing Shown to Increase HIV Detection Yield

By LabMedica International staff writers
Posted on 12 Jul 2010
Community-based HIV testing programs typically use only HIV antibody testing, but nucleic acid testing (NAT) can detect the presence of HIV earlier. More...


Researchers evaluated more than 3,000 patients who sought HIV testing in community-based clinics in or near San Diego (CA, USA) to study the yield of testing with a rapid test plus NAT and to see whether patients would be willing to access their results by phone or computer.

The investigators, from University of California, San Diego (UCSD) School of Medicine (USA), published their study June 14, 2010, in the journal Annals of Internal Medicine, revealed that NAT testing increased the HIV detection yield by 23%, and that a large majority of study participants received their negative test results by automated phone or internet systems.

"While the findings may not be generalized to all populations and testing programs, we did find that NAT programs that include automated systems for result reporting can increase case yield, especially in settings that cater to those men having sex with men," said the study's first author Sheldon Morris, M.D., MPH, assistant clinical professor at UCSD's Antiviral Research Center.

In spite of decades of prevention efforts in the United States, the incidence rate of HIV has remained constant. Because the earliest stages of HIV infection represent a period of maximum infectiousness, early and accurate detection is crucial to control the HIV epidemic. "Extending the use of NAT to routine HIV testing programs might help decrease the HIV incidence rate by identifying persons with acute infection that would otherwise be missed through routine screening,” said Dr. Morris. "In addition, automated reporting of negative results may prove an acceptable and less resource intense alternative to face-to-face reporting.”

The patients were first tested for HIV with a rapid saliva test. If the result was positive, a counselor informed the patient and blood was obtained for a conventional HIV test. If the result was negative, blood was obtained for a NAT. Nearly one quarter of persons with identified cases of HIV had positive results only by NAT testing. More than two-thirds of patients with negative NAT results retrieved them via computer or voicemail.

Most participants in the San Diego study (56%) and those with HIV (91%) were men having sex with men. According to the UCSD researchers, those with higher incomes, younger ages, no testing at substance abuse rehabilitation centers, no recent syphilis, and no methamphetamine use were more likely to access negative NAT results by either internet or voicemail systems.

Related Links:
University of California, San Diego School of Medicine



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.